SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-007980
Filing Date
2024-11-13
Accepted
2024-11-13 16:44:18
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR SEPT 2024 coeptis_i10q-093024.htm   iXBRL 10-Q 1170799
2 CERTIFICATION coeptis_ex3101.htm EX-31.1 7867
3 CERTIFICATION coeptis_ex3102.htm EX-31.2 7804
4 CERTIFICATION coeptis_ex3201.htm EX-32.1 2469
5 CERTIFICATION coeptis_ex3202.htm EX-32.2 2464
  Complete submission text file 0001683168-24-007980.txt   5650908

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE coep-20240930.xsd EX-101.SCH 43011
7 XBRL CALCULATION FILE coep-20240930_cal.xml EX-101.CAL 58167
8 XBRL DEFINITION FILE coep-20240930_def.xml EX-101.DEF 203616
9 XBRL LABEL FILE coep-20240930_lab.xml EX-101.LAB 363217
10 XBRL PRESENTATION FILE coep-20240930_pre.xml EX-101.PRE 300614
67 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_i10q-093024_htm.xml XML 782218
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39669 | Film No.: 241455145
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)